- Home
- NBIX vs DOX Comparison
NBIX vs DOX Comparison
Compare NBIX & DOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- DOX
- Stock Information
- Founded
- NBIX 1992
- DOX 1982
- Country
- NBIX United States
- DOX United States
- Employees
- NBIX N/A
- DOX N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- DOX EDP Services
- Sector
- NBIX Health Care
- DOX Technology
- Exchange
- NBIX Nasdaq
- DOX Nasdaq
- Market Cap
- NBIX 12.4B
- DOX 10.2B
- IPO Year
- NBIX 1996
- DOX 1998
- Fundamental
- Price
- NBIX $134.33
- DOX $88.61
- Analyst Decision
- NBIX Strong Buy
- DOX Strong Buy
- Analyst Count
- NBIX 21
- DOX 4
- Target Price
- NBIX $165.14
- DOX $105.33
- AVG Volume (30 Days)
- NBIX 821.3K
- DOX 738.4K
- Earning Date
- NBIX 07-30-2025
- DOX 08-06-2025
- Dividend Yield
- NBIX N/A
- DOX 2.39%
- EPS Growth
- NBIX N/A
- DOX 6.36
- EPS
- NBIX 2.96
- DOX 4.74
- Revenue
- NBIX $2,412,600,000.00
- DOX $4,752,199,000.00
- Revenue This Year
- NBIX $16.29
- DOX N/A
- Revenue Next Year
- NBIX $15.08
- DOX $4.26
- P/E Ratio
- NBIX $45.11
- DOX $18.83
- Revenue Growth
- NBIX 21.73
- DOX N/A
- 52 Week Low
- NBIX $84.23
- DOX $78.58
- 52 Week High
- NBIX $157.98
- DOX $95.41
- Technical
- Relative Strength Index (RSI)
- NBIX 70.92
- DOX 38.04
- Support Level
- NBIX $127.03
- DOX $91.62
- Resistance Level
- NBIX $135.94
- DOX $93.44
- Average True Range (ATR)
- NBIX 2.85
- DOX 1.64
- MACD
- NBIX 0.47
- DOX -0.38
- Stochastic Oscillator
- NBIX 87.52
- DOX 3.82
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About DOX Amdocs Limited
Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.